These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8631137)

  • 1. Lack of bioavailability of dichlorobenzidine form diarylide azo pigments: molecular dosimetry for hemoglobin and DNA adducts.
    Sagelsdorff P; Haenggi R; Heuberger B; Joppich-Kuhn R; Jung R; Weideli HJ; Joppich M
    Carcinogenesis; 1996 Mar; 17(3):507-14. PubMed ID: 8631137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomonitoring of aromatic amines. IV: Use of hemoglobin adducts to demonstrate the bioavailability of cleavage products from diarylide azo pigments in vivo.
    Zwirner-Baier I; Neumann HG
    Arch Toxicol; 1994; 68(1):8-14. PubMed ID: 8166610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of dichlorobenzidine-hemoglobin adducts by GC/MS-NCI.
    Joppich-Kuhn R; Hänggi R; Sagelsdorff P; Smith AE; Weideli HJ; Joppich M
    Int Arch Occup Environ Health; 1997; 69(4):240-6. PubMed ID: 9137997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of hemoglobin adducts formed in rats exposed orally with 3,3'-dichlorobenzidine by GC/MS-SIM.
    Lee JH; Shin HS
    Toxicol Ind Health; 2002 May; 18(4):191-9. PubMed ID: 12974542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of possible metabolism of pigment yellow 17, a 3,3'-dichlorobenzidine-based pigment, after inhalation exposure in rats.
    Hofmann T; Schmidt D
    Arch Toxicol; 1993; 67(2):141-4. PubMed ID: 8481102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo binding of 3,3'-dichlorobenzidine to rat and mouse tissue DNA.
    Ghosal A; Iba MM
    Cancer Lett; 1990 Sep; 53(2-3):197-204. PubMed ID: 2208080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenicity of azo colorants: influence of solubility and bioavailability.
    Golka K; Kopps S; Myslak ZW
    Toxicol Lett; 2004 Jun; 151(1):203-10. PubMed ID: 15177655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-induced mutagenicity in Salmonella TA102 and genotoxicity/cytotoxicity in human T-cells by 3,3'-dichlorobenzidine: a chemical used in the manufacture of dyes and pigments and in tattoo inks.
    Wang L; Yan J; Hardy W; Mosley C; Wang S; Yu H
    Toxicology; 2005 Feb; 207(3):411-8. PubMed ID: 15664269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary monitoring method of 3,3'-dichlorobenzidine (DCB) and its metabolites, N-acetyl-DCB and N,N'-diacetyl-DCB.
    Lee JH; Shin HS; Jung DG; Lee YS
    Ind Health; 2003 Jul; 41(3):242-8. PubMed ID: 12916755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent interaction of 3,3'-dichlorobenzidine with hepatic lipids. Enzymic basis and stability of the adducts.
    Iba MM; Lang B; Thomas PE; Ghosal A
    Biochem Pharmacol; 1990 Aug; 40(3):581-7. PubMed ID: 2116801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomonitoring of aromatic amines. III: Hemoglobin binding of benzidine and some benzidine congeners.
    Birner G; Albrecht W; Neumann HG
    Arch Toxicol; 1990; 64(2):97-102. PubMed ID: 2350241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible carcinogenic metabolites of azo dye and pigment: trace-level determination of benzidine, 3,3'-dichlorobenzidine and their acetylated and conjugated products in human and hamster urine.
    Bowman MC; Nony CR
    IARC Sci Publ; 1981; (40):193-217. PubMed ID: 7327672
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement by butylated hydroxytoluene of the in vitro activation of 3,3'-dichlorobenzidine.
    Ghosal A; Iba MM
    Mutat Res; 1992 Jan; 278(1):31-41. PubMed ID: 1370117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
    Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin adducts in workers exposed to benzidine and azo dyes.
    Beyerbach A; Rothman N; Bhatnagar VK; Kashyap R; Sabbioni G
    Carcinogenesis; 2006 Aug; 27(8):1600-6. PubMed ID: 16497705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of 3,3'-dichlorobenzidine-mediated toxicity in HepG2 cells.
    Chen LC; Wu JC; Tuan YF; Tseng YK; Hseu YC; Chen SC
    Environ Mol Mutagen; 2014 Jun; 55(5):407-20. PubMed ID: 24604609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis, purification and stability: requirements for a metabolism study of an azo dye and pigment.
    Nony CR; Bowman MC
    J Anal Toxicol; 1980; 4(2):63-7. PubMed ID: 7191457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin and DNA adduct formation in Fischer-344 rats exposed to 2,4- and 2,6-toluene diamine.
    Wilson PM; La DK; Froines JR
    Arch Toxicol; 1996; 70(10):591-8. PubMed ID: 8870951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry.
    Goodenough AK; Schut HA; Turesky RJ
    Chem Res Toxicol; 2007 Feb; 20(2):263-76. PubMed ID: 17305409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of human exposure to the dietary carcinogen 3-amino-1, 4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) from hemoglobin adduct: the relationship to DNA adducts.
    Umemoto A; Monden Y; Grivas S; Yamashita K; Sugimura T
    Carcinogenesis; 1992 Jun; 13(6):1025-30. PubMed ID: 1600606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.